Health outcomes and healthcare resource utilization among Veterans with stage IV non-small cell lung cancer treated with second-line chemotherapy versus immunotherapy

Health outcomes and healthcare resource utilization among Veterans with stage IV non-small cell lung cancer treated with second-line chemotherapy versus immunotherapy

Show other versions (1)

<h4>Background</h4> Until recently, multi-agent chemotherapy (CT) was the standard of care for patients with advanced non-small cell lung cancer (NSCLC). Clinical trials have confirmed benefits in overall survival (OS) and progression-free survival with immunotherapy (IO) compared to CT....

Full description

Bibliographic Details
Main Authors: Christina D. Williams, Mina A. Allo, Lin Gu, Vishal Vashistha, Ashlyn Press, Michael Kelley
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942992/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942992/?tool=EBI

Similar Items